Dario Trapani, MD, is a medical oncologist at the European Institute of Oncology, IRCCS, Milan and Assistant Professor at the Department of Oncology and Haemato-Oncology of the University of Milan, in Italy. Dario has been trained in medical oncology in Milan and at the Dana Farber Cancer Institute in Boston, where he has completed a clinical fellowship in breast oncology. He has been the first ESMO-seconded consultant to the World Health Organization (WHO) within the Cancer Control team, as part of the Noncommunicable Diseases Department. He supported the development of the WHO tool for National Cancer Control Planning and for a Cancer Workforce strategy. As part of his interest in cancer policy, Dario has been a member of, and still collaborates with, the WHO Working Groups involved in priority-setting, including for the selection of Essential Medicines (WHO EML Cancer Working Group), and in the Strategic Advisory Group for Essential Diagnostics (SAGE EDL). At ESMO, he presently serves as the Chair of the Cancer Medicines Committee, and represents ESMO within the European Medicines Agency (EMA) Healthcare Professionals' Working Party.